Immunization, Vaccines and Biologicals

The Global Vaccine and Immunization Research Forum (GVIRF)

Global Vaccine and Immunization Research Forum 2016

The second GVIRF will be held on 15-17 March 2016 at Sandton Hilton Hotel, Johannesburg, South Africa.

The 2016 GVIRF will be discussing major research agendas in support of the objectives of the Global Vaccine Action Plan (GVAP), covering discovery, development and delivery sciences. The scientific programme is being developed by the three co-hosting agencies, The Bill & Melinda Gates Foundation, the US National Institute of Allergy and Infectious Diseases, and the World Health Organization, in conjunction with the Scientific Organizing Committee of the GVIRF.

The forum will gather leading experts from academic and private sector institutions, public health, regulation and civil society organizations. A scientific programme will be posted shortly. Forum attendance is by invitation only.

For further information, please contact Mrs Farah Assil at faraha@who.int

Background

The GVIRF is the forum for the discussion of the research component of the GVAP, developed in the context of the Decade of Vaccines Collaboration and endorsed by the 2012 World Health Assembly. The Forum is co-hosted by WHO, the National Institute of Allergy and Infectious Diseases, and the Bill & Melinda Gates Foundation.

The objective of the GVIRF is to serve as a forum to:

  • track progress and discuss obstacles related to priority vaccine research and development;
  • identify gaps, opportunities and actions for the research and development (R&D) community in the areas of vaccines and immunization;
  • create an opportunity for networking and collaboration among the vaccine R&D and immunization communities; and
  • review progress towards GVAP research and development strategic objectives and goals.

As endorsed by the Decade of Vaccines Collaboration Leadership Council and the WHO Strategic Advisory Group of Experts (SAGE), the GVAP research reporting is conducted every two years by the GVIRF and looks at:

  • expanding capabilities of engagement with end-users,
  • enabling development of new vaccines,
  • accelerating development, licensing and update of vaccines, and
  • improving programme efficiencies and increasing coverage.

Previous vaccine fora

The first Global Vaccine and Immunization Research Forum was held on 4-6 March 2014 in Bethesda, USA.


Share